Other · Protein replacement: phenylalanine · developed by Biomarin Pharm
Pegvaliase-pqpz is a PEGylated phenylalanine ammonia lyase enzyme that converts phenylalanine to ammonia and trans-cinnamic acid, substituting for deficient phenylalanine hydroxylase activity.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Mar 2, 2026). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07477691 | Phase 4 | Phenylketonuria | Recruiting | BMRN |
| NCT05356377 | N/A | Phenylketonurias | Completed | BMRN |
| NCT04404530 | N/A | Phenylketonurias | Recruiting | BMRN |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Phenylketonuria
Updated Nov 8, 2026. Something wrong or missing? Report it on the BMRN page.
See BMRN's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
BMRN catalysts and pipeline →